BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call

AI BRIEFING

• ⬤ BioVersys AG reports Q4 2025 financial results and business update, to host conference call.
• ⬤ BioVersys AG is a multi-asset, clinical stage biopharmaceutical company focused on antibacterial products for MDR bacteria.
• ⬤ Company to discuss financial results and business strategy on conference call.